title: Differential effects of selenium compounds on glucose synthesis in rabbit kidney-cortex tubules and hepatocytes. In vitro and in vivo studies.
abstract: Although selenium is taken with diet mainly as selenoamino acids, its hypoglycaemic action on hepatic gluconeogenesis has been studied with the use of inorganic selenium derivatives. The aim of the present investigation was to compare relative efficacies of inorganic and organic selenium compounds in reducing glucose synthesis in hepatocytes and renal tubules, significantly contributing to the glucose homeostasis. In contrast to hepatocytes, both selenite and methylselenocysteine inhibited renal gluconeogenesis by about 40-45% in control rabbits. Selenate did not affect this process, whereas selenomethionine inhibited gluconeogenesis by about 20% in both hepatocytes and renal tubules. In contrast to methylselenocysteine, selenite decreased intracellular ATP content, glutathione reduced/glutathione oxidized (GSH/GSSG) ratio and pyruvate carboxylase, PEPCK and FBPase activities, while methylselenocysteine diminished PEPCK activity due to elevation of intracellular 2-oxoglutarate and GSSG, inhibitors of this enzyme. Experiments in vivo indicate that in 3 of 9 alloxan-diabetic rabbits treated for 14 days with methylselenocysteine (0.182mg/kg body weight) blood glucose level was normalized, whereas in all diabetic rabbits plasma creatinine and urea levels decreased from 2.52+/-0.18 and 87.4+/-9.7 down to 1.63+/-0.11 and 39.0+/-2.8, respectively. In view of these data selenium supplementation might be beneficial for protection against diabetes-induced nephrotoxicity despite selenium accumulation in kidneys and liver.
authors.affiliation: Department of Metabolic Regulation, Institute of Biochemistry, Faculty of Biology, Warsaw University, ul. Miecznikowa 1, 02-096 Warsaw, Poland.
authors.forename: Anna
authors.initials: A
authors.lastname: Kiersztan
authors.forename: Izabela
authors.initials: I
authors.lastname: Lukasinska
authors.forename: Anna
authors.initials: A
authors.lastname: Baranska
authors.forename: Magdalena
authors.initials: M
authors.lastname: Lebiedzinska
authors.forename: Andrzej
authors.initials: A
authors.lastname: Nagalski
authors.forename: Rafał A
authors.initials: RA
authors.lastname: Derlacz
authors.forename: Jadwiga
authors.initials: J
authors.lastname: Bryla
mesh_terms: D000496:Alloxan; D000818:Animals; D001786:Blood Glucose / Q000187:drug effects*; D003921:Diabetes Mellitus, Experimental / Q000139:chemically induced / Q000378:metabolism; D005943:Gluconeogenesis / Q000187:drug effects*; D005952:Glucose-6-Phosphatase / Q000378:metabolism; D022781:Hepatocytes / Q000187:drug effects* / Q000378:metabolism; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007684:Kidney Tubules / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D011766:Pyruvate Carboxylase / Q000378:metabolism; D011817:Rabbits; D018036:Selenium Compounds / Q000494:pharmacology*
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D018036:Selenium Compounds; D000496:Alloxan; D005952:Glucose-6-Phosphatase; D011766:Pyruvate Carboxylase